The Venture Codex Logo

The Venture Codex

Overview

Biotech startup restoring damaged arteries by targeting elastin.

Total Raised

$10 M

Rounds

2

Links

Verticals

Biopharma
Biotechnology
Therapeutics

Investment History

  1. Equity

    Apr 2022

    $10M

Team

Douglas Mulhall

Co-Founder

Naren Vyavahare

Co-Founder, Chief Scientific Officer

Pedro M. Quintana Diez M.D.

Healthcare

Matthias Breugelmans

Chief Executive Officer